New Hope For Later Stage Prostate Cancer Patients: The PARP Inhibitor Olaparib Approved By The FDA

Updated December 30th, 2022

New Hope For Later Stage Prostate Cancer Patients: The PARP Inhibitor Olaparib Approved By The FDA

The FDA has approved PARP Inhibitor Olaparib for the treatment of advanced prostate cancer patients. Experts say this approval marks new personalized therapy options for specific tumors.

NOW
PLAYING
Zanubrutinib Is A New and Improved Medication For CLL
NOW
PLAYING
Zanubrutinib May Delay Disease Progression in Chronic Lymphocytic Leukemia & Small Lymphocytic Lymphoma
NOW
PLAYING
Is A Restrictive Neutropenic Diet Really Necessary After a Bone Marrow Transplant?
NOW
PLAYING
For Some Advanced Breast Cancers Powered By Estrogen, The Drug Camizestrant Shows Promise Actually Degrading The Hormone
NOW
PLAYING
Real-World Implications Of Her2 Low- The Major New Breast Cancer Designation And Its Treatment-- How Low Is Too Low?
NOW
PLAYING
New Data: The Drug Ibrutinib May Help Some Younger Mantle Cell Lymphoma Patients Avoid A Stem Cell Transplant

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... prostate cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

Later Stage Treatment: New Treatment Developments

SEE MORE   

  • There are several new drugs and treatment options available for those facing advanced stage prostate cancer.
  • Two PARP inhibitors are currently FDA-approved: Lynparza (olaparib) and Rubraca (rucaparib).
  • Two newer androgen deprivation therapies include: Xtandi (enzalutamide) Erleada (apalutamide).

Later Stage Treatment: New Treatment Developments

  • There are several new drugs and treatment options available for those facing advanced stage prostate cancer.
  • Two PARP inhibitors are currently FDA-approved: Lynparza (olaparib) and Rubraca (rucaparib).
  • Two newer androgen deprivation therapies include: Xtandi (enzalutamide) Erleada (apalutamide).
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.